Trabecular outflow facility determined by fluorophotometry in human subjects

Area of Science:

• Ophthalmology
• Optometry
• Pharmacology

Background:

• Trabecular outflow facility is a key determinant of intraocular pressure.
• Accurate measurement of trabecular outflow facility is crucial for understanding glaucoma pathophysiology and drug effects.
• Current methods for assessing trabecular outflow facility can be invasive or complex.

Purpose of the Study:

• To evaluate a novel, non-invasive fluorophotometric method for determining trabecular outflow facility in humans.
• To assess the efficacy of pilocarpine in increasing trabecular outflow facility using this new method.
• To validate the use of levobunolol in conjunction with the method for calculating trabecular outflow facility.

Main Methods:

• A new fluorophotometric technique was developed and applied.
• Pilocarpine, known to increase outflow facility, was used to test the method.
• Levobunolol was administered to reduce intraocular pressure and aqueous humor flow for calculations.
• The study involved ten ocular hypertensive patients.

Main Results:

• Pilocarpine significantly increased trabecular outflow facility (0.42 +/- 0.16) compared to vehicle treatment (0.17 +/- 0.14) (P < 0.004).
• The method demonstrated an ocular hypotensive additivity when both pilocarpine and levobunolol were used.
• The fluorophotometric method provided quantifiable results for trabecular outflow facility.

Conclusions:

• The developed non-invasive fluorophotometric method is effective for measuring trabecular outflow facility.
• This method can reliably assess the impact of drugs, like pilocarpine, on trabecular outflow.
• The technique shows potential for clinical use in evaluating glaucoma treatments.